Clinical Trial Update: Escitalopram Neuroimaging Supplement

View source ↗

Summary

The document notes that a clinical trial evaluating escitalopram with neuroimaging in Body Dysmorphic Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Body Dysmorphic Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Body Dysmorphic Disorder | Status: COMPLETED